File(s) not publicly available
Treatment options for the eradication of intestinal protozoa
journal contribution
posted on 2023-06-08, 10:12 authored by Michael J G FarthingPathogenic intestinal protozoa are responsible for clinically important infections in both the developed and the developing world. These organisms are responsible for both acute and chronic diarrhea, and Entamoeba histolytica, which affects the colon, can spread to involve the liver. Many of these pathogens, particularly the intracellular protozoa that predominantly affect the small intestine, produce their most devastating effects in patients with HIV/AIDS and other forms of immune deficiency. There are also various intestinal protozoa that do not seem to have any adverse effects on humans and can, therefore, be regarded as harmless commensal organisms. Although treatment has been available for several decades for giardiasis, isosporiasis and amoebiasis, until recently there have been no effective remedies for infection with intestinal coccidia—Cryptosporidium, Microsporidium and Cyclospora species. Cyclospora respond well to co-trimoxazole, microsporidia respond variably to albendazole, and cryptosporidia can often be eradicated by nitazoxanide. In chronically infected HIV-positive patients, treatment with multidrug regimens usually results in rapid resolution of the diarrhea and, in many instances, eradication of the parasite.
History
Publication status
- Published
Journal
Nature Clinical Practice: Gastroenterology and HepatologyISSN
1743-4378Publisher
Nature Publishing GroupExternal DOI
Issue
8Volume
3Page range
436-445Department affiliated with
- Clinical and Experimental Medicine Publications
Notes
albendazole; antiprotozoal agents; diarrhea; intestinal protozoa; nitazoxanideFull text available
- No
Peer reviewed?
- Yes
Legacy Posted Date
2012-02-07Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC